参考文献/References:
[1] KARTHIVASHAN G,GANESAN P,PARK S Y,et al.Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson′s disease:from preclinical to translational studies[J].Biomaterials,2020,232:119704.
[2] 崔亚欢,陈乃耀.帕金森病的发病机制研究[J].中华老年心脑血管病杂志,2019,21(1):106-110.
[3] WANG X X,FENG Y,LI X,et al.Prodromal markers of Parkinson′s disease in patients with essential tremor[J].Front Neurol,2020,11:874.
[4] SCHRAG A.Testing the MDS clinical diagnostic criteria for Parkinson′s disease[J].Mov Disord,2018,33(10):1518-1520.
[5] GU S C,YE Q,YUAN C X.Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson′s disease:a systematic review and meta-analysis[J].Rev Neurosci,2019,30(7):743-756.
[6] QU M,LIN Q,HUANG L,et al.Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson′s disease[J].J Control Release,2018,287:156-166.
[7] SONNTAG K C,SONG B,LEE N,et al.Pluripotent stem cell-based therapy for Parkinson′s disease:current status and future prospects[J].Prog Neurobiol,2018,168:1-20.
[8] ZANIGNI S,TESTA C,CALANDRA-BUONAURA G,et al.The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes[J].Parkinsonism Relat Disord,2015,21(8):929-37.
[9] XU H,ZHANG H,ZHANG J,et al.Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy:implications for psychiatric disorders[J].Neurosci Biobehav Rev,2016,71:563-577.
[10] VON JONQUIERES G,SPENCER Z H T,ROWLANDS B D,et al.Uncoupling N-acetylaspartate from brain pathology:implications for canavan disease gene therapy[J].Acta Neuropathol,2018,135(1):95-113.
[11] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.
[12] 中华医学会神经病学分会帕金森病及运动障碍学组.中国帕金森病治疗指南(第三版)[J].中华神经科杂志,2014,47(6):428-433.
[13] GOETZ C G,TILLEY B C,SHAFTMAN S R,et al.Movement Disorder Society-sponsored revision of the Unified Parkinson′s Disease Rating Scale (MDS-UPDRS):scale presentation and clinimetric testing results[J].Mov Disord,2008,23(15):2129-70.
[14] 梁建庆.帕金森病的发病机制、诊断标准及治疗策略[J].解放军医学杂志,2018,43(8):631-635.
[15] PARK G H J,YANG S H,BAEK H M.900MHz 1H-/13C-NMR analysis of 2-hydroxyglutarate and other brain metabolites in human brain tumor tissue extracts [J].PLoS One,2018,13(9):e0203379.
[16] WESLEY U V,BHUTE V J,HATCHER J F,et al.Local and systemic metabolic alterations in brain,plasma,and liver of rats in response to aging and ischemic stroke,as detected by nuclear magnetic resonance (NMR) spectroscopy [J].Neurochem Int,2019,127:113-124.
[17] ORBAN A,GARG G,SAMMI M K,et al.Effect of high-intensity exercise on multiple sclerosis function and phosphorous magnetic resonance spectroscopy outcomes[J].Med Sci Sports Exerc,2019,51(7):1380-1386.
[18] SAILASUTA N,ANANWORANICH J,LERDLUM S,et al.Neuronal-glia markers by magnetic resonance spectroscopy in HIV before and after combination antiretroviral therapy [J].J Acquir Immune Defic Syndr,2016,71(1):24-30.
[19] BOBAN J,KOZIC D,TURKULOV V,et al.HIV-associated neurodegeneration and neuroimmunity:multivoxel MR spectroscopy study in drug-nave and treated patients[J].Eur Radiol,2017,27 (10):4218-4236.
[20] SARAC H,OZRETIC D,HENIGSBERG N,et al.Proton magnetic resonance spectroscopy in huntington′s disease accompanying neuroborreliosis[J].Psychiatr Danub,2017,29(2):226-230.
[21] SHEN Z,LEI J,LI X,et al.Multifaceted assessment of the APP/PS1 mouse model for Alzheimer′s disease:applying MR-S,DTI,and ASL [J].Brain Res,2018,1698:114-120.
[22] BURMANN B M,GEREZ J A,MATECKO-BURMANN I,et al.Regulation of α-synuclein by chaperones in mammalian cells [J].Nature,2020,577(7788):127-132.
[23] CHAUDHARY S,KUMARAN S S,GOYAL V,et al.Frontal lobe metabolic alterations characterizing Parkinson′s disease cognitive impairment [J].Neurol Sci,2021,42(3):1053-1064.
[24] 庄蓉,张辉,职璞,等.磁共振波谱在强迫障碍中的研究进展[J].国际精神病学杂志,2020,47(2):227-229,246.
[25] WANG W,SUN H,SU X,et al.Increased right amygdala metabolite concentrations in the absence of atrophy in children and adolescents with PTSD [J].Eur Child Adolesc Psychiatry,2019,28(6):807-817.
相似文献/References:
[1]马琪林,鲁丛霞,蔡琰,等.帕金森病患者血小板线粒体谷氨酸载体和复合物活性研究 [J].新乡医学院学报,2007,24(02):114.
[2]洪丽,李珂,闫晓海,等.瞬目反射与肛门括约肌肌电图对帕金森病患者病情分期判定的意义[J].新乡医学院学报,2012,29(12):936.
[3]朱丰霞,常海敏,段 瑛,等.人参皂苷 Rg1对帕金森病小鼠黑质中酪氨酸羟化酶及ephrinB2和磷酸化 c-Jun表达的影响[J].新乡医学院学报,2014,31(10):781.[doi:10.7683/xxyxyxb.2014.10.003]
[4]魏家彬,杨 帆,王淑秀.人参皂苷Rg1对1甲基4苯基1,2,3,6四氢吡啶诱导的帕金森病小鼠黑质酪氨酸蛋白激酶A4表达的影响[J].新乡医学院学报,2015,32(05):404.
[5]李 乐,黄志勇,贺文麟.血浆同型半胱氨酸、催乳素水平与帕金森病及帕金森病痴呆相关性分析[J].新乡医学院学报,2015,32(05):438.
[6]宋金辉,王普清,丁旭东,等.节律性视觉刺激对帕金森病患者运动功能及平衡能力的影响[J].新乡医学院学报,2014,31(12):1006.[doi:10.7683/xxyxyxb.2014.12.011]
[7]孙 冰,徐玉英.氧化苦参碱对帕金森小鼠中枢神经系统氧化应激的影响[J].新乡医学院学报,2020,37(6):509.[doi:10.7683/xxyxyxb.2020.06.002]
SUN Bing,XU Yuying.Effects of oxymatrine on oxidative stress of central nervous system in Parkinson mice[J].Journal of Xinxiang Medical University,2020,37(8):509.[doi:10.7683/xxyxyxb.2020.06.002]
[8]张静怡,邓永宁,张 萌,等.Sirt3基因过表达慢病毒载体的构建及其在人神经母细胞瘤SH-SY5Y细胞中的表达[J].新乡医学院学报,2021,38(1):006.[doi:10.7683/xxyxyxb.2021.01.002]
ZHANG Jingyi,DENG Yongning,ZHANG Meng,et al.Construction of lentiviral vector with Sirt3 gene overexpression and its expression in human neuroblastoma SH-SY5Y cells[J].Journal of Xinxiang Medical University,2021,38(8):006.[doi:10.7683/xxyxyxb.2021.01.002]
[9]赵雪薇,陈珮琪,牛延翔,等.帕金森病的病因及发病机制研究进展[J].新乡医学院学报,2021,38(4):378.[doi:10.7683/xxyxyxb.2021.04.018]
[10]谷晓源,车祥源,马 静,等.过氧化物酶体增殖物激活受体γ辅激活剂-1α rs2946385基因多态性与帕金森病的相关性[J].新乡医学院学报,2021,38(9):822.[doi:10.7683/xxyxyxb.2021.09.005]
GU Xiaoyuan,CHE Xiangyuan,MA Jing,et al.Correlation between peroxisome proliferator-activated receptor γ coactivator 1α rs2946385 gene polymorphism and Parkinson′s disease[J].Journal of Xinxiang Medical University,2021,38(8):822.[doi:10.7683/xxyxyxb.2021.09.005]